Get the Stockscreener App
6.585
2.75%
0.185
After Hours:
6.58
-0.005
-0.08%
Inogen Inc stock is traded at $6.585, with a volume of 293.07K.
It is up +2.75% in the last 24 hours and down -6.73% over the past month.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
See More
Previous Close:
$6.40
Open:
$6.41
24h Volume:
293.07K
Relative Volume:
0.89
Market Cap:
$178.42M
Revenue:
$348.67M
Net Income/Loss:
$-22.75M
P/E Ratio:
-7.6829
EPS:
-0.8571
Net Cash Flow:
$-21.60M
1W Performance:
+1.95%
1M Performance:
-6.73%
6M Performance:
-7.64%
1Y Performance:
+0.70%
1-Day Range:
$6.365
$6.66
1-Week Range:
$6.17
$6.66
52-Week Range:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.59 | 173.28M | 348.67M | -22.75M | -21.60M | -0.8571 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | B. Riley Securities | Buy |
| May-22-25 | Upgrade | Needham | Hold → Buy |
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Q3 2025 Inogen Inc Earnings Call Transcript - GuruFocus
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Yahoo Finance
Inogen Earnings Call: International Strength Amid U.S. Strain - TipRanks
Inogen stock (US45780L1044): respiratory player in focus after Q1 2026 update and restructuring plan - AD HOC NEWS
Inogen, IncCommon Stock (NQ: INGN - The Chronicle-Journal
Number of shareholders of Inogen, Inc. – FWB:6IO - TradingView
Inogen Q1 2026 slides: revenue beats amid profitability pressure By Investing.com - Investing.com Nigeria
Inogen Q1 2026 slides: revenue beats amid profitability pressure - Investing.com
Earnings call transcript: Inogen’s mixed Q1 2026 results with revenue beat - Investing.com Nigeria
Needham Upgrades Inogen (INGN) - MSN
How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions - Yahoo Finance
Here's why you should retain Inogen stock in your portfolio for now - MSN
Inogen, Inc. (NASDAQ:INGN) Q1 2026 Earnings Call Transcript - Insider Monkey
Inogen (INGN) TTM Loss Narrows To US$22.7 Million Testing Bearish Profitability Narratives - Sahm
Inogen Inc. Earnings Call Highlights Transition Phase - TipRanks
Inogen (NASDAQ: INGN) Q1 2026 revenue rises 3% as net loss widens - Stock Titan
Inogen Inc stock (US45780L1044): Q1 revenue growth and valuation debate - AD HOC NEWS
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves - sharewise.com
Q1 2026 Inogen Inc Earnings Call Transcript - GuruFocus
Inogen, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Inogen Q1 2026 presentation shows revenue beat, widening losses By Investing.com - Investing.com Canada
Inogen (INGN) Reports Strong Q1 Revenue Growth - GuruFocus
Inogen: Q1 Earnings Snapshot - theheraldreview.com
Earnings call transcript: Inogen Q1 2026 shows revenue beat, EPS miss - Investing.com UK
Inogen Inc 1Q 2026: Revenue $85.1M, EPS $(0.30) — 10-Q Summary - TradingView
Inogen Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Inogen Q1 2026 shows revenue beat, EPS miss By Investing.com - Investing.com South Africa
Inogen Q1 2026 presentation shows revenue beat, widening losses - Investing.com
Inogen (INGN) Q1 2026 Earnings Transcript - The Globe and Mail
Inogen (NASDAQ:INGN) Q1 2026 Earnings: Revenue Beat Masks Guidance Miss, Stock Dips - ChartMill
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Inogen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Inogen, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-05-07 - Seeking Alpha
Inogen : Supplemental Financials Q1 2026 - marketscreener.com
Inogen (Nasdaq: INGN) Q1 2026 revenue up 3.4% as losses widen - Stock Titan
Inogen Announces First Quarter 2026 Financial Results - marketscreener.com
The moat Inogen (INGN) is building for long term dominance (Smart Money Active) 2026-05-06Investment Signal Network - newser.com
Here's Why You Should Add Inogen Stock to Your Portfolio Now - MSN
Inogen Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Inogen (NASDAQ: INGN) 2026 proxy targets board elections and declassification - Stock Titan
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Inogen Inc Stock (INGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off |
Mar 01 '26 |
Option Exercise |
0.00 |
25,017 |
0 |
33,699 |
| Ramade Gregoire | Chief Commercial Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
13,005 |
0 |
50,251 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Mar 01 '26 |
Option Exercise |
0.00 |
14,005 |
0 |
28,283 |
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 01 '26 |
Option Exercise |
0.00 |
42,007 |
0 |
100,949 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '26 |
Option Exercise |
0.00 |
58,346 |
0 |
147,973 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '25 |
Option Exercise |
0.00 |
31,566 |
0 |
50,189 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '25 |
Option Exercise |
0.00 |
28,334 |
0 |
100,108 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Sep 01 '25 |
Option Exercise |
0.00 |
18,135 |
0 |
20,821 |
1.35%
2.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):